Psychological burden of psoriatic patients in a German university hospital dermatology department
- PMID: 33354818
- DOI: 10.1111/1346-8138.15721
Psychological burden of psoriatic patients in a German university hospital dermatology department
Abstract
Psoriasis has a strong impact on patients' lives and is closely linked to psychiatric disorders such as depression, anxiety and substance-related disorders, especially dependence on alcohol and nicotine. The aim of our study was to systematically assess the psychiatric comorbidity and possible associations between psychological factors, disease severity and dermatology-related quality of life in psoriatic patients from a high-need university hospital dermatology department. Consecutive psoriatic patients (new and permanent patients) at the Department of Dermatology, University Hospital Essen, Germany, were asked to fill out a paper-based questionnaire. In the first part of the questionnaire, baseline demographics, pre-existing mental disorders and data on substance abuse were collected. In the second part of the questionnaire, mental and physical health was explored using different validated self-rating tests. The current Psoriasis Area and Severity Index (PASI) was documented by a dermatologist. Patients with signs of mental disorders were offered an appointment with a board-certified psychiatrist. Between August 2016 and February 2019, 228 consecutive psoriatic patients (138 men [60.5%], 90 women [39.5%]; mean age, 48.3 years [standard deviation, 13.6; range, 18-80]) participated in the study. Approximately 50% of the patients had evidence of suffering from mental health problems, mostly depression and anxiety, as well as alcohol dependence. Patients with a PASI of 3 or more showed a statistically significant reduced Dermatology Life Quality Index (DLQI) and a significantly impaired psychological as well as physical quality of life. DLQI correlated with all psychological test results. The data indicate a significant psychological burden in a tertiary psoriatic population. Our findings underscore the importance of screening psoriatic patients for psychiatric disorders, with a focus on depression, anxiety as well as alcohol and nicotine dependence, in a multidimensional approach involving psychiatrists and psychologists.
Keywords: Patient Health Questionnaire; Short Form Health Survey-36; depression; psoriasis; psychological burden.
© 2020 The Authors. The Journal of Dermatology published by John Wiley & Sons Australia, Ltd on behalf of Japanese Dermatological Association.
Similar articles
-
Psychosocial burden and body mass index are associated with dermatology-related quality of life in psoriasis patients.Eur J Dermatol. 2020 Apr 1;30(2):140-147. doi: 10.1684/ejd.2020.3755. Eur J Dermatol. 2020. PMID: 32538356
-
Disease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan.Prim Care Companion CNS Disord. 2015 Jun 25;17(3):10.4088/PCC.14m01629. doi: 10.4088/PCC.14m01629. eCollection 2015. Prim Care Companion CNS Disord. 2015. PMID: 26644955 Free PMC article.
-
Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: A cross-sectional study of outpatient clinic patients in the biologic treatment era.RMD Open. 2020 May;6(1):e001223. doi: 10.1136/rmdopen-2020-001223. RMD Open. 2020. PMID: 32409518 Free PMC article.
-
Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI).Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S64-85. doi: 10.1002/acr.20577. Arthritis Care Res (Hoboken). 2011. PMID: 22588772 Review. No abstract available.
-
Decision-Analytic Modeling for Time-Effectiveness of the Sequence of Induction Treatments for Moderate to Severe Plaque Psoriasis.JAMA Dermatol. 2019 Dec 1;155(12):1380-1389. doi: 10.1001/jamadermatol.2019.2941. JAMA Dermatol. 2019. PMID: 31617856 Free PMC article.
Cited by
-
Systemic Psoriasis: From Molecular Mechanisms to Global Management Strategies.Clin Rev Allergy Immunol. 2025 Aug 7;68(1):79. doi: 10.1007/s12016-025-09089-4. Clin Rev Allergy Immunol. 2025. PMID: 40775488 Review.
-
Common Fundamentals of Psoriasis and Depression.Acta Derm Venereol. 2021 Nov 30;101(11):adv00609. doi: 10.2340/actadv.v101.565. Acta Derm Venereol. 2021. PMID: 34806760 Free PMC article.
-
[Inpatient care for psoriasis: quo vadis?-A retrospective study at the University Hospitals of Aachen, Bonn, and Essen from 2010 to 2019].Dermatologie (Heidelb). 2024 Feb;75(2):170-175. doi: 10.1007/s00105-023-05234-2. Epub 2023 Oct 11. Dermatologie (Heidelb). 2024. PMID: 37819277 Review. German.
-
New Access Routes to Undertreated Populations; How Do Problem Substance Users Recruited from an Unemployment Office Differ from Detoxification Treatment Inpatients?Int J Environ Res Public Health. 2021 Dec 9;18(24):13014. doi: 10.3390/ijerph182413014. Int J Environ Res Public Health. 2021. PMID: 34948622 Free PMC article.
-
The Impact of Psoriasis and Atopic Dermatitis on Quality of Life: A Literature Research on Biomarkers.Life (Basel). 2022 Dec 5;12(12):2026. doi: 10.3390/life12122026. Life (Basel). 2022. PMID: 36556392 Free PMC article. Review.
References
REFERENCES
-
- Augustin M, Reich K, Glaeske G, Schaefer I, Radtke M. Co-morbidity and age-related prevalence of psoriasis: analysis of health insurance data in Germany. Acta Derm Venereol. 2010;90:147-51.
-
- Schafer I, Rustenbach SJ, Radtke M, Augustin J, Glaeske G, Augustin M. Epidemiology of psoriasis in Germany-analysis of secondary health insurance data. Gesundheitswesen. 2011;73:308-13.
-
- Boehncke WH, Boehncke S, Tobin AM, Kirby B. The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol. 2011;20:303-7.
-
- Mrowietz U, Steinz K, Gerdes S. Psoriasis: to treat or to manage? Exp Dermatol. 2014;23:705-9.
-
- Patel N, Nadkarni A, Cardwell LA, Vera N, Frey C, Patel N, et al. Psoriasis, depression, and inflammatory overlap: a review. Am J Clin Dermatol. 2017;18:613-20.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical